Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5201
|
pubmed:dateCreated |
1969-8-22
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0028-0836
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
5
|
pubmed:volume |
223
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
81-2
|
pubmed:dateRevised |
2006-9-25
|
pubmed:meshHeading |
pubmed-meshheading:4978300-Antigens,
pubmed-meshheading:4978300-Australia,
pubmed-meshheading:4978300-Blood Transfusion,
pubmed-meshheading:4978300-Carrier State,
pubmed-meshheading:4978300-Hepatitis B,
pubmed-meshheading:4978300-Humans,
pubmed-meshheading:4978300-Immunodiffusion,
pubmed-meshheading:4978300-Time,
pubmed-meshheading:4978300-Time Factors
|
pubmed:year |
1969
|
pubmed:articleTitle |
Persistence of the serum hepatitis (SH-Australia) antigen for many years.
|
pubmed:publicationType |
Journal Article
|